SINGAPORE CLINICAL RESEARCH INSTITUTE
🇸🇬Singapore
- Country
- 🇸🇬Singapore
- Ownership
- -
- Established
- 2008-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.scri.edu.sg/scri/
Clinical Trials
3
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:2
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 4
1 (33.3%)Safety Study of Human MUC-1 (Mucin-1) Adenoviral Vector Vaccine for Immunotherapy of Epithelial Cancers
Phase 1
- Conditions
- Epithelial Cancers of the Lung, Breast, Ovary, Prostate and Colon
- Interventions
- Drug: Ad-sig-hMUC-1/ecdCD40L vector vaccine
- First Posted Date
- 2014-05-16
- Last Posted Date
- 2016-10-14
- Lead Sponsor
- Singapore Clinical Research Institute
- Target Recruit Count
- 24
- Registration Number
- NCT02140996
- Locations
- 🇸🇬
National Cancer Centre Singapore, Singapore, Singapore
🇸🇬National Cancer Centre, Singapore, Singapore
The Effect of 90-day Oral Testosterone Therapy in Chinese Males With Type 2 Diabetes (T2DM)
Phase 4
Terminated
- Conditions
- Assess the Effects of a the 90-day Oral TS Study Regimen on PSA, IPSS, Haemoglobin and Haematocrit, and to Assess Adverse and Serious Adverse Events.
- Interventions
- First Posted Date
- 2012-01-18
- Last Posted Date
- 2016-01-06
- Lead Sponsor
- Singapore Clinical Research Institute
- Target Recruit Count
- 19
- Registration Number
- NCT01510847
- Locations
- 🇸🇬
Camry Medical Centre, Singapore, Singapore
🇸🇬Frontier Medical Associates (Ubi) Pte Ltd, Singapore, Singapore
🇸🇬Everhealth Medical Centre, Singapore, Singapore
Study of SIR-Spheres Plus Sorafenib as 1st Line Treatment for Non-resectable Primary Hepatocellular Carcinoma (HCC)
Phase 1
Completed
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Radiation: SIR-Spheres
- First Posted Date
- 2008-07-10
- Last Posted Date
- 2016-01-06
- Lead Sponsor
- Singapore Clinical Research Institute
- Target Recruit Count
- 35
- Registration Number
- NCT00712790
- Locations
- 🇰🇷
Seoul National University Bundang Hospital, Seoul, Korea, Republic of
🇲🇾Selayang Hospital, Selangor, Malaysia
🇲🇲Yangon GI & Liver Centre, Yangon, Myanmar
News
No news found